Abstract:Male reproductive toxicity examines harmful effects of various agents on all aspects and developmental stages of the male reproductive system, including germ cell development and spermatogenesis. In developing a model for reproductive toxicity screening it is important to define the developmental stage that this model is going to recreate in vitro and to identify critical molecular targets of this stage. In this review we focus our discussion on the potential for using embryonic stem cell (ESC)-derived models for male reproductive toxicity screening. The rationale for developing novel toxicity models is that despite significant advances in our biological understanding and clinical treatment of infertility, many unresolved cases still remain. This is likely due to our lack of knowledge about environmental influences on the critical stages of gamete development. Many practical and ethical difficulties are associated with the collection of human tissue samples to explore the unknown causes of infertility. Thus, a readily available in vitro model that mimics human gamete development would be an extremely valuable research tool for establishing novel toxicity assays. ESC exhibit a high degree of similarity with primordial germ cells (PGC) at the level of gene expression and molecular signaling. In addition, recent evidence shows that ESC can be differentiated into PGC and spermatids in culture. Multiple lines of evidence point to the differences between mouse and human ESC (hESC). In light of these data, we present the case that hESC are better suited as in vitro toxicity screening models than their mouse counterparts. We then describe some of the most promising hESC-based systems that are used today to model certain aspects of male gamete development and that have a potential to be used for toxicity screening. We conclude by discussing the potential of these existing models in toxicology studies and the possibilities for their improvement in the future.

[Development of Human Embryonic Stem Cell Model for Toxicity Evaluation].

Evaluation of human embryonic stem cells and their differentiated fibroblastic progenies as cellular models for in vitro genotoxicity screening.

Differentiated Fibroblastic Progenies of Human Embryonic Stem Cells for Toxicology Screening

Human Embryonic Stem Cells May Display Higher Resistance to Genotoxic Stress As Compared to Primary Explanted Somatic Cells.

Evaluating Biotoxicity with Fibroblasts Derived from Human Embryonic Stem Cells.

[Progress in the Derivation, Culture of Human Embryonic Stem Cells].

Pluripotent Stem Cells: an in Vitro Model for Nanotoxicity Assessments

Derivation, Characterization and Differentiation of a New Human Embryonic Stem Cell Line from a Chinese Hatched Blastocyst Assisted by a Non-Contact Laser System

[Development of Human Embryonic Stem Cell Platforms for Human Health-Safety Evaluation].

Use of Human Embryonic Stem Cell-based Models for Male Reproductive Toxicity Screening

Advancing Environmental Toxicology In Vitro: From Immortalized Cancer Cell Lines to 3D Models Derived from Stem Cells

[Application of Keratinocytes Derived from Human Embryonic Stem Cells for Toxicological Evaluation of Drugs].

Establishment of a human embryonic stem cell-based liver differentiation model for hepatotoxicity evaluations

Development of a TBXT-EGFP iPS cell model for screening the early developmental toxicity of typical environmental pollutants

The Construction of Stem Cell-Induced Hepatocyte Model and Its Application in Evaluation of Developmental Hepatotoxicity of Environmental Pollutants

The application of human-derived cell lines in neurotoxicity studies of environmental pollutants

Human Pluripotent Stem Cell-Based Assays to Predict Developmental Toxicity

Advancements in stem cell-derived hepatocyte-like cell models for hepatotoxicity testing

Establishment and Maintenance of Three Chinese Human Embryonic Stem Cell Lines

Application of stem cells in the study of developmental and functional toxicity of endodermal-derived organs caused by nanoparticles

Pluripotent stem cells for target organ developmental toxicity testing